DESCRIPTION OF THE ‘MYSTERIOUS HEPATITIS’ VIRUS IN CHILDREN AFTER COVID-19

Reading time is 3 mins

.
.
DESCRIPTION OF THE ‘MYSTERIOUS HEPATITIS’ VIRUS

Turkey Medicals – in cases of mysterious hepatitis virus seen in 13 countries, there has been no transmission from one to the other. “All 170 reported cases are independent patients. That’s why we don’t expect much from something like the Covid-19 pandemic spreading from one country to another,” was said.

The occurrence of hepatitis cases in close to 200 children in the United States, Great Britain, Spain, Israel, Denmark, Ireland, Italy, Norway, France, Romania, Belgium, the Netherlands and Canada has raised the risk of a global epidemic.

Turkey Medicals said that hepatitis, in the general sense, means the bankruptcy of the liver. Noting that there are many reasons for this; but the most common causes are viruses called ‘viral hepatitis’ factors.

“Type ‘A’ and type ‘B’ species are very common in these as well. Type ‘A‘ is more commonly known as ’infectious jaundice’ in the general public. It is transmitted by sexual contact with food, but more often with water and food contaminated with the feces of a sick person.

Hepatitis B is a type of hepatitis that is more commonly transmitted by sexual contact with blood and has more serious consequences; it can be in the form of cirrhosis, cancer. The remaining ‘C’ type, ‘D’ type, and ‘E’ type hepatitis are slightly less common.

Turkey has been widely vaccinating all children against type ‘B’ since 1999 and type ‘A’ since 2012. ”We have started to see very little of this type of hepatitis, but this latest virus has actually not been a virus that we have seen much in hepatitis until now,” was said.

.
THERE WAS NO TRANSMISSION FROM ONE TO THE OTHER

Turkey Medicals reminded the World Health Organization (WHO) that a total of 170 cases have been reported from around the world in this way,

“Of this, 115 were reported from the UK. So a thought was born that ‘there may be a causative adenovirus’, but we are still in some doubt because we know that adenovirus does not do such a thing. So it’s not a very accepted event.

In these cases, there was no transmission from one to the other. all 170 cases are independent patients.

That’s why we don’t expect much from something like the Covid-19 pandemic spreading from one country to another. Even if it spreads, it will not be a big spread quickly. A little time will also tell you how quickly it will spread.

In addition, Covid-19 has been observed in only 20 percent of these cases. This is no longer unexpected, as children already have Covid-19 at this time. So this has nothing to do with Covid-19.

However, this has nothing to do with Covid-19; when you remove the Covid-19 measures, the child encounters this virus. His immunity is also not enough. As a result, there is a risk of getting sick,” was said.

.
IT HASN’T BEEN SEEN IN TURKEY, WE CAN’T SAY

Turkey Medicals also spoke about the risk of developing mysterious hepatitis in Turkey:

“We can’t say ’not seen in Turkey’, no one can say. Because the first is adenovirus, the notification of which is not an obligatory disease. For example, ‘Is chickenpox seen in Turkey right now?’ if you say it, it can be answered because it’s a mandatory disease.

Every doctor who sees chickenpox has to report it to the ministry, but doctors who don’t have to report it when adenovirus is detected. That’s why we don’t know his number. Secondly, because there is no virus that we know as a hepatitis factor, adenovirus has not been looked at in cases of hepatitis, adenovirus has not been looked at so far.

For example, we sometimes look at respiratory tract viruses using the scanning method. We have also seen 2 cases in our scan since January. But we didn’t detect this adenovirus in them, but another virus. Therefore, if the causative virus is adenovirus, we have not seen it so far, but we have seen cases similar to this related to another virus,” Turkey Medicals said.

.
.
.
.

Follow me
President of Organ Transplant Center at MedicalPark Hospital Antalya

Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.

Physician's Resume:

Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.

Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.

In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.

Awards:

Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.

Certificates:

Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .

Professional Members:

American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.

Disclaimer:

Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.
Medically Reviewed by Professor Doctor Alper Demirbaş
Follow me